2025 annual financial data
Relmada Therapeutics 2025 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -59,100,200 USD and net income was -57,385,163 USD.
Operating cash flow was -45,786,988 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -59,100,200 USD
- Net income
- -57,385,163 USD
- Operating cash flow
- -45,786,988 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Relmada Therapeutics financial years